vimarsana.com


Anteris Technologies achieves breakthrough in ADAPT® products to create consistently thin tissue
The proven benefits of its ADAPT® tissue technology, paired with DurAVR™’s unique 3D single piece aortic valve design, have potential to deliver a functional cure to aortic stenosis patients and provide a much-needed solution to the challenges facing heart surgeons.
Anteris a structural heart company delivering clinically superior and durable solutions through better science and better design.
Anteris Technologies Ltd (ASX:AVR) has achieved a breakthrough in manufacturing the tissue used in ADAPT® treated products from bovine pericardium, after developing specialised machinery to create consistently thin tissue through an innovative processing technique.

Related Keywords

,Transcatheter Valve Therapies ,Structural Heart Summit ,Call For Innovation ,கட்டமைப்பு இதயம் உச்சிமாநாடு ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.